Advertisement

Topics

Avitide, Inc., Raises Series E Financing from Sands Capital Ventures with Broad Participation from Early Investors

08:00 EDT 21 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Ian Ratcliffe to Join Avitide’s Board of Directors Avitide, Inc., the industry leader in the discovery, and manufacture of exclusive biopharmaceutical affinity purification solutions, today announced the closing of a Serie...

Other Sources for this Article

MacDougall Biomedical Communications
Cammy Duong, 781-591-3443
cduong@macbiocom.com

NEXT ARTICLE

More From BioPortfolio on "Avitide, Inc., Raises Series E Financing from Sands Capital Ventures with Broad Participation from Early Investors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...